Status:
UNKNOWN
Impact of the CareLink Express Remote Monitoring System on Early Detection of Atrial Fibrillation
Lead Sponsor:
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study results will be used to check the hypothesis that CareLink Express remote monitoring system increases the detection rate of asymptomatic AF and allows to change timely the treatment strategy...
Detailed Description
It is expected to enroll 200 consecutive patients without previously diagnosed AF, who have indications for implantation of dual chamber cardiac pacemakers according to the current guidelines. All the...
Eligibility Criteria
Inclusion
- patients with indications for implantation of dual chamber cardiac pacemaker
- patients with no AF history;
- written informed consent.
Exclusion
- patients with contraindications for CIED implantation;
- patients with previously implanted CIEDs;
- infection;
- patients with previously diagnosed AF
Key Trial Info
Start Date :
September 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 21 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04306978
Start Date
September 21 2017
End Date
January 21 2023
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Institute for Complex Problems of Cardiovascular Diseases
Kemerovo, Russia, 650061